期刊
BIOORGANIC CHEMISTRY
卷 110, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bioorg.2021.104793
关键词
Colchicine binding site; Inhibitors; Tetrahydro-quinoxaline derivatives; Antitumor activities
资金
- National Natural Science Foundation of China [81903443]
- Key Scientific and Technological Project of Henan Province [192102310146, 212102310316]
- Key Scientific Research Program of the Higher Education Institutions of Henan Province [20A310003]
Colchicine binding site inhibitors have great potential for treating tumors. Tetrahydro-quinoxaline derivatives designed in this study showed promising antitumor activities, with compound 11a being the most potent candidate.
Colchicine binding site inhibitors (CBSIs) hold great potential for the treatment of various tumors and they can overcome multidrug resistance which the existing tubulin inhibitors such as paclitaxel and vinorelbine are faced with. Herein, we report the design, synthesis and biological evaluation of a series of tetrahydro-quinoxaline derivatives as colchicine binding site inhibitors. All the synthesized compounds were evaluated for their in vitro antiproliferative activities against HT-29 and Hela cancer cell lines, and most of the target compounds demonstrated moderate to strong activities towards two tumor cell lines. In addition, the structure-activity relationships of these derivatives were also discussed. Among them, compounds 11a and 11b showed the most potent activities. Moreover, compound 11a inhibited the tubulin polymerization in both cell-free and cellular assays. Further profiling of compound 11a revealed that it arrested cell cycle in G2/M and induced cell apoptosis in a dose-dependent manner. Furthermore, molecular docking study proved that compound 11a acted on the colchicine binding site. Therefore, 11a is a promising candidate for the discovery of colchicine binding site inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据